Regenerative Medicine Trials in Brazil

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Regenerative Medicine Trials in Brazil

Regenerative Medicine Trials in Brazil – Human Trials in LATAM

Regenerative medicine stands at the forefront of medical innovation, offering the potential to revolutionize the treatment of various diseases and injuries by harnessing the body’s natural healing processes. In recent years, Brazil has emerged as a trailblazer in the field of regenerative medicine trials.

This blog takes you on a journey through the dynamic landscape of regenerative medicine trials in Brazil, highlighting the remarkable strides, challenges, and the transformative impact these trials hold for healthcare.

The Brazilian Vanguard of Regenerative Medicine

Regenerative medicine encompasses a wide spectrum of approaches, including stem cell therapy, tissue engineering, and gene editing. Brazil’s thriving research community has embraced these avenues to explore novel treatments and therapies that have the potential to reshape the future of medicine.

Stem Cell Therapy Breakthroughs

Stem cell therapy, a cornerstone of regenerative medicine, has gained substantial traction in Brazil. Clinical trials are underway to investigate the efficacy of mesenchymal stem cells (MSCs) derived from various sources, including bone marrow and adipose tissue.

These trials target a range of conditions, from orthopedic injuries to autoimmune disorders, showcasing Brazil’s commitment to providing cutting-edge solutions to diverse medical challenges. The country’s advances in stem cell research place it at the forefront of regenerative medicine innovation.

Tissue Engineering Innovations

Tissue engineering, a discipline focused on creating functional tissues and organs, has also found fertile ground in Brazil. Researchers are actively engaged in trials aimed at developing tissue-engineered solutions for wound healing, cartilage regeneration, and organ transplantation. These efforts underscore Brazil’s dedication to advancing medical science and providing innovative therapies that address critical healthcare needs.

Gene Editing Frontiers

The groundbreaking potential of gene editing technologies has captured the attention of researchers in Brazil. Gene therapy trials are exploring ways to modify genetic material to treat inherited diseases and genetic disorders.

By targeting the root causes of these conditions, these trials hold the promise of offering transformative treatments that were once thought to be beyond the realm of possibility. Brazil’s involvement in gene editing research underscores its commitment to pushing scientific boundaries and driving medical progress.

Regenerative Medicine Trials in Brazil

Regenerative Medicine Trials in Brazil

Regenerative Medicine Trials in Brazil

Navigating Challenges and Ethical Considerations

Regenerative medicine trials in Brazil, like any scientific endeavor, come with their share of challenges. Ethical considerations surrounding stem cell research, genetic modification, and patient safety require careful scrutiny.

Ensuring that trials adhere to rigorous ethical standards and adhere to international guidelines is of paramount importance. Brazilian regulatory bodies and research institutions are actively addressing these challenges to ensure that scientific advancement goes hand in hand with ethical responsibility.

Global Collaboration and Knowledge Sharing

Brazil’s pursuit of regenerative medicine excellence extends beyond its borders through collaborations and partnerships with international research institutions. By fostering connections and sharing knowledge with experts worldwide, Brazil seeks to accelerate its progress and contribute to the global regenerative medicine community.

These collaborations facilitate the exchange of ideas, expertise, and resources, propelling the field forward and cementing Brazil’s position as a leader in medical innovation.

Potential Transformative Impact on Healthcare

The potential impact of regenerative medicine trials in Brazil goes beyond scientific advancement. Successful outcomes could lead to the development of groundbreaking treatments for a wide range of conditions, improving patient outcomes and reducing healthcare burdens. Furthermore, Brazil’s emergence as a regenerative medicine powerhouse could attract medical tourism, driving economic growth and enhancing its reputation as a hub for medical excellence.


Brazil’s journey into the realm of regenerative medicine trials is a testament to its commitment to scientific progress and healthcare innovation. Stem cell therapy, tissue engineering, and gene editing trials represent the country’s pioneering spirit and determination to push the boundaries of medical science.

As Brazil tackles ethical considerations and collaborates with global partners, it is poised to play a pivotal role in shaping the future of regenerative medicine. The ongoing trials serve as a beacon of hope, not only for patients within Brazil but for the broader global community seeking transformative medical solutions.

Regenerative Medicine Trials in Brazil

Source: Duke Clinical Research Institute

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Regenerative Medicine Trials in Brazil

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
Regenerative Medicine Trials in Brazil

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Regenerative Medicine Trials in Brazil

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Regenerative Medicine Trials in Brazil

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

Regenerative Medicine Trials in Brazil

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

Regenerative Medicine Trials in Brazil

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
Regenerative Medicine Trials in Brazil

The Cohortias Team

Regenerative Medicine Trials in Brazil

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Regenerative Medicine Trials in Brazil

Network & Partnerships